$5.48
0.15[2.81%]
Last update: 7:18AM Get Real Time Here
Capricor Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Capricor Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/13/2024 | PM | CAPR | Q1 | -$0.31 | -$0.11 | — | — | $2.99M | $9.70M | — | — | Get Alert |
02/29/2024 | PM | CAPR | Q4 | -$0.31 | -$0.09 | -$0.02 | 77.78% | $959.90K | $10.60M | $12.09M | 14.04% | Get Alert |
11/14/2023 | PM | CAPR | Q3 | -$0.26 | -$0.29 | -$0.25 | 13.79% | $1.59M | $2.11M | $6.18M | 193.13% | Get Alert |
08/07/2023 | PM | CAPR | Q2 | -$0.29 | -$0.35 | -$0.29 | 17.14% | $0.00 | $1.50M | $3.92M | 161.13% | Get Alert |
05/11/2023 | PM | CAPR | Q1 | -$0.32 | -$0.32 | -$0.31 | 3.12% | $0.00 | $500.00K | $2.99M | 497.40% | Get Alert |
03/15/2023 | PM | CAPR | Q4 | -$0.26 | -$0.33 | -$0.31 | 6.06% | $0.00 | — | $959.90K | — | Get Alert |
11/10/2022 | PM | CAPR | Q3 | -$0.17 | -$0.29 | -$0.26 | 10.34% | $0.00 | $210.00K | $1.59M | 658.10% | Get Alert |
08/10/2022 | PM | CAPR | Q2 | -$0.22 | — | -$0.29 | — | $204.08K | — | $0.00 | — | Get Alert |
05/10/2022 | PM | CAPR | Q1 | -$0.23 | — | -$0.32 | — | $40.82K | — | $0.00 | — | Get Alert |
03/10/2022 | PM | CAPR | Q4 | -$0.21 | -$0.19 | -$0.26 | -36.84% | $57.83K | — | $0.00 | — | Get Alert |
11/09/2021 | PM | CAPR | Q3 | -$0.20 | -$0.22 | -$0.17 | 22.73% | $16.86K | $210.00K | $0.00 | -100.00% | Get Alert |
08/12/2021 | PM | CAPR | Q2 | -$0.23 | -$0.23 | -$0.22 | 4.35% | $49.86K | $210.00K | $204.08K | -2.82% | Get Alert |
05/13/2021 | PM | CAPR | Q1 | -$0.30 | — | -$0.23 | — | $185.69K | — | $40.82K | — | Get Alert |
03/11/2021 | PM | CAPR | Q4 | -$0.34 | — | -$0.21 | — | $222.10K | $210.00K | $57.83K | -72.46% | Get Alert |
11/12/2020 | PM | CAPR | Q3 | -$0.43 | -$0.37 | -$0.20 | 45.95% | $142.07K | $210.00K | $16.86K | -91.97% | Get Alert |
08/06/2020 | PM | CAPR | Q2 | -$0.59 | -$0.34 | -$0.23 | 32.35% | $410.35K | $210.00K | $49.86K | -76.26% | Get Alert |
05/14/2020 | PM | CAPR | Q1 | -$0.80 | -$0.33 | -$0.30 | 9.09% | $230.50K | $210.00K | $185.69K | -11.57% | Get Alert |
03/18/2020 | PM | CAPR | Q4 | -$1.10 | -$0.34 | -$0.34 | 0.00% | $648.08K | — | $222.10K | — | Get Alert |
11/07/2019 | PM | CAPR | Q3 | -$1.40 | -$0.70 | -$0.43 | 38.57% | $219.25K | $200.00K | $142.07K | -28.96% | Get Alert |
Capricor Therapeutics (CAPR) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
The Actual EPS was $-0.02, which beat the estimate of $-0.09.
The Actual Revenue was $12.1M, which beat the estimate of $10.6M.
Browse earnings estimates, EPS, and revenue on all stocks.